Log in

Aerpio Pharmaceuticals Stock Forecast, Price & News

-0.05 (-3.23 %)
(As of 09/18/2020 12:00 AM ET)
Today's Range
Now: $1.50
50-Day Range
MA: $1.40
52-Week Range
Now: $1.50
Volume3.75 million shs
Average Volume1.54 million shs
Market Capitalization$63.10 million
P/E RatioN/A
Dividend YieldN/A
Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes proprietary therapeutics for treating ocular diseases. The company's lead product candidate is AKB-9778, a small molecule activator of the tie-2 pathway, which completed Phase 2a clinical trials for the treatment of diabetic macular edema. It also develops ARP-1536, a humanized monoclonal antibody that is in late stage preclinical development for the treatment of wet age-related macular degeneration; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a Phase 1a clinical trial for the treatment of inflammatory bowel disease. The company is headquartered in Cincinnati, Ohio.
Read More
Aerpio Pharmaceuticals logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.28 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:ARPO



Sales & Book Value

Annual SalesN/A



Market Cap$63.10 million
Next Earnings DateN/A
OptionableNot Optionable
-0.05 (-3.23 %)
(As of 09/18/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ARPO News and Ratings via Email

Sign-up to receive the latest news and ratings for ARPO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Aerpio Pharmaceuticals (OTCMKTS:ARPO) Frequently Asked Questions

How has Aerpio Pharmaceuticals' stock price been impacted by COVID-19?

Aerpio Pharmaceuticals' stock was trading at $0.54 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ARPO stock has increased by 177.8% and is now trading at $1.50.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of Aerpio Pharmaceuticals?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aerpio Pharmaceuticals in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Aerpio Pharmaceuticals

How were Aerpio Pharmaceuticals' earnings last quarter?

Aerpio Pharmaceuticals Inc (OTCMKTS:ARPO) released its quarterly earnings results on Wednesday, August, 12th. The company reported $0.23 EPS for the quarter, missing the consensus estimate of $0.27 by $0.04.
View Aerpio Pharmaceuticals' earnings history

What price target have analysts set for ARPO?

1 brokers have issued 12 month price objectives for Aerpio Pharmaceuticals' shares. Their forecasts range from $2.00 to $2.00. On average, they anticipate Aerpio Pharmaceuticals' share price to reach $2.00 in the next year. This suggests a possible upside of 33.3% from the stock's current price.
View analysts' price targets for Aerpio Pharmaceuticals

Who are some of Aerpio Pharmaceuticals' key competitors?

What other stocks do shareholders of Aerpio Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aerpio Pharmaceuticals investors own include Bausch Health Companies (BHC), Trevena (TRVN), VBI Vaccines (VBIV), Ampio Pharmaceuticals (AMPE), Actinium Pharmaceuticals (ATNM), Corbus Pharmaceuticals (CRBP), MannKind (MNKD), Sorrento Therapeutics (SRNE), Aldeyra Therapeutics (ALDX) and Biocept (BIOC).

Who are Aerpio Pharmaceuticals' key executives?

Aerpio Pharmaceuticals' management team includes the following people:
  • Dr. Joseph H. Gardner, Founder, Pres & Director (Age 62)
  • Mr. Kevin G. Peters M.D., Ph.D., Chief Scientific Officer & Sr. VP (Age 61)
  • Dr. Stephen Pakola M.D., Chief Medical Officer (Age 49)
  • Dr. Stephen J. Hoffman, CEO & Director (Age 64)
  • Mr. Michael W. Rogers, Chief Financial Officer (Age 58)

What is Aerpio Pharmaceuticals' stock symbol?

Aerpio Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ARPO."

Who are Aerpio Pharmaceuticals' major shareholders?

Aerpio Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional investors include Johnson Investment Counsel Inc. (0.79%), HighTower Advisors LLC (0.09%), Goldman Sachs Group Inc. (0.07%) and Two Sigma Securities LLC (0.06%). Company insiders that own Aerpio Pharmaceuticals stock include Bioventures Ltd Novartis, Joseph H Gardner, Muneer A Satter and Stephen J Hoffman.
View institutional ownership trends for Aerpio Pharmaceuticals

Which major investors are selling Aerpio Pharmaceuticals stock?

ARPO stock was sold by a variety of institutional investors in the last quarter, including HighTower Advisors LLC.
View insider buying and selling activity for Aerpio Pharmaceuticals

Which major investors are buying Aerpio Pharmaceuticals stock?

ARPO stock was bought by a variety of institutional investors in the last quarter, including Johnson Investment Counsel Inc., Goldman Sachs Group Inc., and Two Sigma Securities LLC. Company insiders that have bought Aerpio Pharmaceuticals stock in the last two years include Joseph H Gardner, Muneer A Satter, and Stephen J Hoffman.
View insider buying and selling activity for Aerpio Pharmaceuticals

How do I buy shares of Aerpio Pharmaceuticals?

Shares of ARPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Aerpio Pharmaceuticals' stock price today?

One share of ARPO stock can currently be purchased for approximately $1.50.

How big of a company is Aerpio Pharmaceuticals?

Aerpio Pharmaceuticals has a market capitalization of $63.10 million.

What is Aerpio Pharmaceuticals' official website?

The official website for Aerpio Pharmaceuticals is www.aerpio.com.

How can I contact Aerpio Pharmaceuticals?

Aerpio Pharmaceuticals' mailing address is 9987 CARVER ROAD, CINCINNATI OH, 45242. The company can be reached via phone at 513-985-1920 or via email at [email protected]

This page was last updated on 9/19/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.